{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T10:55:34Z","timestamp":1781520934215,"version":"3.54.1"},"reference-count":15,"publisher":"FapUNIFESP (SciELO)","issue":"3","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"am","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100020410","name":"Health Institutes of Turkey","doi-asserted-by":"crossref","award":["39800"],"award-info":[{"award-number":["39800"]}],"id":[{"id":"10.13039\/100020410","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Rev. Assoc. Med. Bras."],"abstract":"<jats:p>SUMMARY  OBJECTIVE: Non-muscle invasive bladder cancer is a common urological malignancy characterized by high recurrence and progression rates. There is a critical need for non-invasive biomarkers to support early detection and disease monitoring. Raftlin, a lipid raft-associated scaffold protein involved in immune regulation and signal transduction, has recently gained attention in cancer biology. The aim of this study was to investigate serum Raftlin levels and the rs690037 polymorphism of the Raftlin gene in non-muscle invasive bladder cancer patients.  METHODS: A case-control study was conducted, including 30 patients diagnosed with non-muscle invasive bladder cancer and 50 healthy controls. Serum Raftlin levels were measured using enzyme-linked immunosorbent assay, and the rs690037 polymorphism was analyzed using real-time polymerase chain reaction. Gender-stratified analysis and receiver operating characteristic curve analysis were performed. Clinical and pathological characteristics including tumor stage, grade, and European Organisation for Research and Treatment of Cancer risk groups, were analyzed.  RESULTS: Serum Raftlin levels were significantly elevated in non-muscle invasive bladder cancer patients compared to healthy controls (p&lt;0.001). Gender-stratified analysis confirmed this association was independent of gender (males: p&lt;0.001; females: p&lt;0.001). Receiver operating characteristic curve analysis demonstrated an area under the curve of 0.987 (95%CI 0.966\u20131.000), with an optimal cut-off of 5.28 ng\/mL providing 96.7% sensitivity and 98.0% specificity. Trends toward higher Raftlin levels were observed in more aggressive disease features. No significant association was found between the rs690037 polymorphism and disease presence.  CONCLUSION: This pilot study suggests that serum Raftlin levels are significantly elevated in non-muscle invasive bladder cancer and show high discriminatory ability. While preliminary findings suggest potential as a non-invasive biomarker, validation in larger, independent cohorts is required before clinical implementation.<\/jats:p>","DOI":"10.1590\/1806-9282.20251628","type":"journal-article","created":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T10:35:40Z","timestamp":1781519740000},"source":"Crossref","is-referenced-by-count":0,"title":["Elevated serum Raftlin levels in non-muscle invasive bladder cancer: diagnostic implications and rs690037 genotype analysis"],"prefix":"10.1590","volume":"72","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7498-604X","authenticated-orcid":false,"given":"Senay","family":"Balci","sequence":"first","affiliation":[{"name":"Mersin University,  Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7004-790X","authenticated-orcid":false,"given":"Rojda","family":"Tanriverdi","sequence":"additional","affiliation":[{"name":"Mersin University,  Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6325-1534","authenticated-orcid":false,"given":"Ali","family":"Nebio\u011flu","sequence":"additional","affiliation":[{"name":"Mersin City Training and Research Hospital,  Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7709-6133","authenticated-orcid":false,"given":"Didem Derici","family":"Yildirim","sequence":"additional","affiliation":[{"name":"Mersin University,  Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0535-9966","authenticated-orcid":false,"given":"Cemil","family":"G\u00fcl\u00fcm","sequence":"additional","affiliation":[{"name":"Mersin University,  Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8624-0149","authenticated-orcid":false,"given":"Murat","family":"Bozlu","sequence":"additional","affiliation":[{"name":"Mersin University,  Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0997-0260","authenticated-orcid":false,"given":"L\u00fcl\u00fcfer","family":"Tamer","sequence":"additional","affiliation":[{"name":"Mersin University,  Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"530","published-online":{"date-parts":[[2026]]},"reference":[{"issue":"3","key":"ref1","first-page":"209","article-title":"Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung H","year":"2021","journal-title":"CA Cancer J Clin"},{"issue":"2","key":"ref2","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.eururo.2012.07.033","article-title":"Epidemiology and risk factors of urothelial bladder cancer","volume":"63","author":"Burger M","year":"2013","journal-title":"Eur Urol"},{"issue":"5","key":"ref3","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1016\/j.eururo.2019.08.016","article-title":"European Association of Urology Guidelines on non-muscle-invasive bladder cancer (TaT1 and Carcinoma In Situ) - 2019 update","volume":"76","author":"Babjuk M","year":"2019","journal-title":"Eur Urol"},{"issue":"3","key":"ref4","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1016\/j.eururo.2005.12.031","article-title":"Predicting recurrence and progression in individual patients with stage Ta T1 bladder cancer using EORTC risk tables: a combined analysis of 2596 patients from seven EORTC trials","volume":"49","author":"Sylvester RJ","year":"2006","journal-title":"Eur Urol"},{"issue":"1","key":"ref5","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.eururo.2015.06.045","article-title":"EORTC Nomograms and Risk Groups for predicting recurrence, progression, and disease-specific and overall survival in non-muscle-invasive stage Ta-T1 urothelial bladder cancer patients treated with 1-3 years of maintenance Bacillus Calmette-Gu\u00e9rin","volume":"69","author":"Cambier S","year":"2016","journal-title":"Eur Urol"},{"issue":"1","key":"ref6","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1159\/000369357","article-title":"Molecular markers for bladder cancer screening, early diagnosis, and surveillance: the WHO\/ICUD consensus","volume":"94","author":"Schmitz-Dr\u00e4ger BJ","year":"2015","journal-title":"Urol Int"},{"issue":"1","key":"ref7","article-title":"Lipid raft involvement in signal transduction in cancer cell survival, cell death and metastasis","volume":"55","author":"Li B","year":"2022","journal-title":"Cell Prolif"},{"issue":"12","key":"ref8","doi-asserted-by":"crossref","first-page":"3015","DOI":"10.1093\/emboj\/cdg293","article-title":"The B cell-specific major raft protein, Raftlin, is necessary for the integrity of lipid raft and BCR signal transduction","volume":"22","author":"Saeki K","year":"2003","journal-title":"EMBO J"},{"issue":"1","key":"ref9","doi-asserted-by":"crossref","first-page":"4972","DOI":"10.1038\/s41467-023-40622-1","article-title":"ROR\u03b3t-Raftlin1 complex regulates the pathogenicity of Th17 cells and colonic inflammation","volume":"14","author":"Singh AK","year":"2023","journal-title":"Nat Commun"},{"issue":"1","key":"ref10","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1186\/s13019-024-03296-4","article-title":"Could serum Raftlin and GPER-1levels be new biomarkers for early detection of non-small cell lung cancer?","volume":"20","author":"Eli\u00e7ora A","year":"2025","journal-title":"J Cardiothorac Surg"},{"issue":"1","key":"ref11","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1186\/s12885-021-07888-4","article-title":"Multi-omics analysis of genomics, epigenomics and transcriptomics for molecular subtypes and core genes for lung adenocarcinoma","volume":"21","author":"Zhao Y","year":"2021","journal-title":"BMC Cancer"},{"issue":"2","key":"ref12","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1167\/iovs.11-8277","article-title":"Interactive effects of ATOH7 and RFTN1 in association with adult-onset primary open-angle glaucoma","volume":"53","author":"Chen JH","year":"2012","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"7203","key":"ref13","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1038\/nature07205","article-title":"Cancer-related inflammation","volume":"454","author":"Mantovani A","year":"2008","journal-title":"Nature"},{"issue":"3","key":"ref14","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1007\/s10456-020-09715-z","article-title":"Raftlin is recruited by neuropilin-1 to the activated VEGFR2 complex to control proangiogenic signaling","volume":"23","author":"Bayliss AL","year":"2020","journal-title":"Angiogenesis"},{"issue":"1","key":"ref15","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1186\/s13062-024-00562-2","article-title":"RNF19A inhibits bladder cancer progression by regulating ILK ubiquitination and inactivating the AKT\/mTOR signalling pathway","volume":"19","author":"Deng H","year":"2024","journal-title":"Biol Direct"}],"container-title":["Revista da Associa\u00e7\u00e3o M\u00e9dica Brasileira"],"original-title":[],"link":[{"URL":"http:\/\/www.scielo.br\/scielo.php?script=sci_pdf&pid=S0104-42302026000302211&tlng=en","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T10:35:43Z","timestamp":1781519743000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.scielo.br\/scielo.php?script=sci_arttext&pid=S0104-42302026000302211&tlng=en"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026]]},"references-count":15,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2026]]}},"alternative-id":["S0104-42302026000302211"],"URL":"https:\/\/doi.org\/10.1590\/1806-9282.20251628","relation":{},"ISSN":["1806-9282","0104-4230"],"issn-type":[{"value":"1806-9282","type":"electronic"},{"value":"0104-4230","type":"print"}],"subject":[],"published":{"date-parts":[[2026]]},"article-number":"e20251628"}}